One-liner#

Abnormal vaginal discharge requires differentiation between vaginitis (BV, yeast, trich) and cervicitis (chlamydia, gonorrhea)—with treatment based on clinical findings, wet prep, or syndromic approach.

Quick nav#

Red flags / send to ED#

  • Fever + pelvic pain + discharge → PID; if severe or unable to tolerate PO, needs IV antibiotics
  • Pregnant + fever + discharge → risk of chorioamnionitis, preterm labor
  • Toxic-appearing with vaginal symptoms → consider toxic shock syndrome

Key history#

Characterize the discharge:

  • Color: white, gray, yellow, green
  • Consistency: thick/cottage cheese, thin/watery, frothy
  • Odor: fishy (BV, trich), none (yeast), foul
  • Amount: increased from baseline
  • Duration

Associated symptoms:

  • Itching: prominent with yeast, present with trich
  • Dysuria: external (yeast, trich) vs internal (UTI)
  • Dyspareunia: suggests cervicitis, PID, or atrophy
  • Pelvic/abdominal pain: concerning for PID
  • Vulvar irritation, burning

Risk factors:

  • Recent antibiotics (yeast)
  • New sexual partner, multiple partners (STI, BV)
  • Unprotected intercourse
  • Douching (BV)
  • Diabetes, immunosuppression (recurrent yeast)
  • IUD (actinomyces, PID risk)
  • Postmenopausal (atrophic vaginitis)

Menstrual history:

  • LMP, cycle regularity
  • Pregnancy possibility
  • Postmenopausal status

Prior episodes:

  • Recurrent yeast infections
  • Prior STIs
  • What treatments have worked before

Focused exam#

External genitalia:

  • Erythema, edema, excoriations (yeast, trich)
  • Lesions, ulcers (herpes, syphilis)
  • Vulvar atrophy (postmenopausal)

Speculum exam:

  • Vaginal discharge: character, amount, location
  • Vaginal walls: erythema, petechiae (“strawberry cervix” with trich—rare)
  • Cervix: discharge from os (cervicitis), friability, lesions

Bimanual exam:

  • Cervical motion tenderness (CMT) → PID
  • Adnexal tenderness → PID, TOA
  • Uterine tenderness

Key exam findings by diagnosis:

  • BV: thin, gray, homogeneous discharge coating vaginal walls; fishy odor
  • Yeast: thick, white, “cottage cheese” discharge; vulvar erythema, edema
  • Trichomoniasis: frothy, yellow-green discharge; vulvar erythema; strawberry cervix (rare)
  • Cervicitis: mucopurulent discharge from cervical os; cervical friability

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Bacterial vaginosis“Fishy smell,” “grayish discharge,” “worse after sex”Thin gray discharge, fishy odor (especially post-coital), minimal itchingThin gray homogeneous discharge; pH >4.5; positive whiff testWet prep or clinical diagnosis; metronidazole
Vulvovaginal candidiasis“Itchy,” “cottage cheese,” “thick white discharge”Intense pruritus, thick white discharge, recent antibiotics, diabetesVulvar erythema, edema; thick white discharge; pH <4.5Clinical diagnosis or wet prep; fluconazole or topical azole
Trichomoniasis“Frothy discharge,” “yellow-green,” “itchy and burning”Frothy yellow-green discharge, vulvar irritation, STI riskFrothy discharge; strawberry cervix (rare); pH >4.5Wet prep or NAAT; metronidazole
Cervicitis (chlamydia)“Discharge,” “bleeding after sex,” “partner tested positive”Mucopurulent cervical discharge, may be asymptomatic, young/sexually activeMucopurulent discharge from os; cervical friabilityNAAT for CT/GC; treat empirically if high suspicion
Cervicitis (gonorrhea)“Yellow discharge,” “pelvic pain,” “partner has something”Purulent discharge, more symptomatic than chlamydiaPurulent cervical discharge; friabilityNAAT for CT/GC; treat empirically
Physiologic discharge“More discharge than usual,” “no smell or itch”Clear/white, no odor, no itching, varies with cycleNormal exam; clear mucoid dischargeReassurance; no treatment needed
Atrophic vaginitis“Dry,” “discharge,” “painful sex,” postmenopausalPostmenopausal, vaginal dryness, dyspareunia, may have thin dischargePale, dry vaginal mucosa; loss of rugae; petechiaeVaginal estrogen

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
PID“Pelvic pain,” “fever,” “hurts during sex”Lower abdominal pain, fever, cervical discharge, sexually activeCMT, adnexal tenderness, feverTreat empirically; if severe, ED for IV antibiotics
Tubo-ovarian abscess“Severe pelvic pain,” “high fever,” “very sick”Severe pain, high fever, may have palpable massAdnexal mass/fullness, severe tenderness, feverED for imaging and IV antibiotics
Desquamative inflammatory vaginitis“Discharge won’t go away,” “painful,” “tried everything”Chronic purulent discharge, dyspareunia, not responding to standard treatmentPurulent discharge, vaginal erythema, epithelial erosionsGynecology referral
Foreign body“Forgot tampon,” “bad smell,” “bloody discharge”Foul-smelling discharge, may have forgotten tampon or other objectForeign body visible on speculum examRemove foreign body; antibiotics if infection

Workup#

Office-based testing (if available):

  • Vaginal pH: <4.5 (yeast, physiologic) vs >4.5 (BV, trich, atrophic)
  • Wet prep (saline): clue cells (BV), trichomonads (motile), WBCs
  • KOH prep: pseudohyphae/budding yeast (candida); whiff test (fishy odor = BV)
  • Whiff test: add KOH to discharge; fishy odor positive in BV

Amsel criteria for BV (3 of 4):

  1. Thin, homogeneous gray discharge
  2. Vaginal pH >4.5
  3. Positive whiff test
  4. Clue cells on wet prep (>20%)

If no microscopy available:

  • Syndromic treatment based on clinical presentation
  • Send vaginal swab for BV/yeast/trich panel (PCR-based)
  • NAAT for chlamydia/gonorrhea

STI testing:

  • NAAT for chlamydia and gonorrhea (vaginal swab preferred; urine acceptable)
  • Trichomonas NAAT (more sensitive than wet prep)
  • Consider HIV, syphilis, hepatitis B if new STI diagnosis

When to test for STIs:

  • All sexually active women <25 annually
  • New or multiple partners
  • Partner with STI
  • Mucopurulent cervical discharge
  • Cervical friability

When NOT to order:

  • Do NOT treat asymptomatic BV (except in pregnancy)
  • Do NOT routinely culture for yeast—clinical diagnosis usually sufficient
  • Do NOT order “vaginitis panel” for every discharge complaint—targeted testing is more appropriate

Initial management#

BV:

  • Metronidazole (oral or vaginal)
  • No need to treat male partners

Yeast:

  • Fluconazole (oral) or topical azole
  • OTC options appropriate for uncomplicated cases

Trichomoniasis:

  • Metronidazole (oral)
  • MUST treat partners
  • Test for other STIs

Cervicitis/suspected STI:

  • Treat empirically if high suspicion
  • Treat partners
  • Test for HIV, syphilis

PID:

  • Outpatient treatment if mild-moderate and can tolerate PO
  • ED if: severe, pregnant, TOA suspected, unable to tolerate PO

Management by diagnosis#

Bacterial Vaginosis#

Education:

  • Imbalance of normal vaginal bacteria; not an STI
  • Associated with sexual activity but not transmitted sexually
  • Recurrence is common (30% within 3 months)
  • Avoid douching

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Metronidazole500 mg PO BID x 7 daysAvoid alcohol (disulfiram reaction)None$First-line; warn about alcohol
Metronidazole gel 0.75%5 g intravaginally daily x 5 daysNoneNone$$Alternative; less GI side effects
Clindamycin cream 2%5 g intravaginally at bedtime x 7 daysNoneNone$$Alternative; may weaken latex condoms
Clindamycin300 mg PO BID x 7 daysNoneNone$Oral alternative
Secnidazole (Solosec)2 g PO single doseAvoid alcoholNone$$$$Single-dose option; expensive

Recurrent BV (3+ episodes/year):

  • Metronidazole gel 0.75% twice weekly x 4-6 months (suppressive)
  • Consider boric acid 600 mg intravaginally daily x 21 days, then twice weekly

Pregnancy:

  • Treat symptomatic BV
  • Metronidazole 500 mg PO BID x 7 days (safe in pregnancy)
  • Metronidazole gel less effective in pregnancy

Follow-up: None needed if symptoms resolve. No test of cure required.

Vulvovaginal Candidiasis#

Education:

  • Yeast infection; not an STI
  • Common after antibiotics, in diabetes, with immunosuppression
  • OTC treatments work well for uncomplicated cases
  • Partners do not need treatment unless symptomatic (rare)

Uncomplicated (sporadic, mild-moderate, likely C. albicans, immunocompetent):

DrugDoseContraindicationsMonitoringCostNotes
Fluconazole150 mg PO x 1Pregnancy (1st trimester); drug interactionsNone$Most convenient; avoid in pregnancy
Miconazole 2% cream5 g intravaginally daily x 7 daysNoneNone$OTC; safe in pregnancy
Miconazole 200 mg suppository1 suppository daily x 3 daysNoneNone$OTC; safe in pregnancy
Clotrimazole 1% cream5 g intravaginally daily x 7 daysNoneNone$OTC; safe in pregnancy
Terconazole 0.4% cream5 g intravaginally daily x 7 daysNoneNone$$Prescription; for resistant cases

Complicated candidiasis:

  • Severe symptoms: fluconazole 150 mg, repeat in 72 hours
  • Non-albicans species: longer course (7-14 days); boric acid 600 mg intravaginally daily x 14 days
  • Immunocompromised: longer course; may need maintenance

Recurrent candidiasis (4+ episodes/year):

  • Induction: fluconazole 150 mg every 72 hours x 3 doses
  • Maintenance: fluconazole 150 mg weekly x 6 months
  • Check HbA1c (rule out diabetes)
  • Consider HIV testing

Pregnancy:

  • Topical azoles only (7-day course preferred)
  • Avoid oral fluconazole (teratogenic in 1st trimester)

Follow-up: None needed if symptoms resolve. Return if recurrent.

Trichomoniasis#

Education:

  • STI caused by parasite
  • Partners MUST be treated
  • Can be asymptomatic, especially in men
  • Increases HIV transmission risk
  • Abstain until both partners treated and asymptomatic

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Metronidazole500 mg PO BID x 7 daysAvoid alcohol x 24 hours afterNone$Preferred in women; better cure rate
Metronidazole2 g PO single doseAvoid alcohol x 24 hours afterNone$Alternative; slightly lower cure rate
Tinidazole2 g PO single doseAvoid alcohol x 72 hours afterNone$$Alternative if metronidazole fails

Partner treatment:

  • Treat all partners from past 60 days
  • Expedited partner therapy where legal

Pregnancy:

  • Metronidazole 2 g single dose (safe in all trimesters)
  • Treat to prevent preterm birth and transmission

Follow-up: Retest in 3 months (high reinfection rate). Test of cure only if symptoms persist.

Cervicitis (Chlamydia/Gonorrhea)#

Education:

  • Bacterial infection; curable with antibiotics
  • Partners must be treated
  • Can lead to PID and infertility if untreated
  • Abstain until treatment complete and partners treated

Treatment:

For chlamydia:

DrugDoseContraindicationsMonitoringCostNotes
Doxycycline100 mg PO BID x 7 daysPregnancyNone$Preferred; more effective than azithromycin
Azithromycin1 g PO x 1NoneNone$Alternative if adherence concern

For gonorrhea (always co-treat for chlamydia):

DrugDoseContraindicationsMonitoringCostNotes
Ceftriaxone500 mg IM x 1Severe cephalosporin allergyNone$Required for gonorrhea
PLUS Doxycycline100 mg PO BID x 7 daysPregnancyNone$Covers chlamydia

Pregnancy:

  • Chlamydia: azithromycin 1 g x 1 (doxycycline contraindicated)
  • Gonorrhea: ceftriaxone 500 mg IM + azithromycin 1 g

Follow-up: Rescreen in 3 months. Test of cure only if pregnant or symptoms persist.

PID (Pelvic Inflammatory Disease)#

Education:

  • Infection of uterus, tubes, and/or ovaries
  • Usually from untreated STI ascending from cervix
  • Can cause infertility, chronic pain, ectopic pregnancy
  • Partners must be treated

Outpatient criteria (all must be met):

  • Mild-moderate symptoms
  • Tolerating oral intake
  • Can return for follow-up in 48-72 hours
  • Not pregnant

Outpatient treatment:

DrugDoseContraindicationsMonitoringCostNotes
Ceftriaxone500 mg IM x 1Severe cephalosporin allergyNone$Covers gonorrhea
PLUS Doxycycline100 mg PO BID x 14 daysPregnancyNone$Covers chlamydia, other organisms
PLUS Metronidazole500 mg PO BID x 14 daysAvoid alcoholNone$Covers anaerobes; add if severe or TOA concern

ED referral indications:

  • Severe illness, high fever, unable to tolerate PO
  • Pregnant
  • Tubo-ovarian abscess suspected
  • No improvement after 48-72 hours of outpatient treatment
  • Surgical emergency cannot be excluded

Follow-up: 48-72 hours to assess response. If not improving, imaging and possible hospitalization.

Atrophic Vaginitis#

Education:

  • Due to low estrogen after menopause
  • Causes dryness, irritation, and sometimes discharge
  • Vaginal estrogen is safe and effective
  • Takes 4-6 weeks for full benefit

Treatment: See dysuria page for vaginal estrogen options.

Follow-up: 4-6 weeks to assess response.

Follow-up#

BV, yeast, trichomoniasis:

  • No routine follow-up if symptoms resolve
  • Return if symptoms persist or recur

STIs (chlamydia, gonorrhea):

  • Rescreen in 3 months (high reinfection rate)
  • Ensure partners treated

PID:

  • 48-72 hours to assess response
  • If not improving, imaging and possible hospitalization

Return precautions:

  • Fever or pelvic pain (suggests PID)
  • Symptoms not improving after treatment
  • Symptoms recurring shortly after treatment
  • New symptoms (rash, joint pain)

Patient instructions#

For bacterial vaginosis:

  • Take your medication as prescribed
  • Avoid alcohol while taking metronidazole and for 24 hours after
  • This is not a sexually transmitted infection, but it’s associated with sexual activity
  • Avoid douching—it disrupts normal vaginal bacteria
  • Your partner does not need treatment

For yeast infection:

  • You can use over-the-counter treatments if you’ve had yeast infections before and recognize the symptoms
  • If using fluconazole, one pill is usually enough
  • Your partner does not need treatment unless they have symptoms
  • Call if symptoms don’t improve in a few days or keep coming back

For STIs:

  • Take all your medication as prescribed
  • Your partner(s) MUST be treated, or you will get reinfected
  • Do not have sex until you and your partner have finished treatment (at least 7 days)
  • Get tested again in 3 months
  • Call if you develop fever, pelvic pain, or symptoms get worse

Smartphrase snippets#

BV: “Vaginal discharge consistent with bacterial vaginosis—thin gray discharge, positive whiff test, pH >4.5. Treated with metronidazole 500 mg BID x 7 days. Counseled to avoid alcohol during treatment. Partner treatment not indicated. Return if symptoms persist or recur.”

Yeast infection: “Symptoms and exam consistent with vulvovaginal candidiasis—pruritus, thick white discharge, vulvar erythema, pH <4.5. Treated with fluconazole 150 mg x 1. If recurrent, will evaluate for diabetes and consider suppressive therapy.”

Cervicitis/STI: “Mucopurulent cervical discharge consistent with cervicitis. NAAT sent for CT/GC. Treated empirically with [ceftriaxone 500 mg IM + doxycycline 100 mg BID x 7 days]. Partner treatment discussed; EPT provided. Advised abstinence x 7 days. Will rescreen in 3 months.”